Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Experimental Physiology 92.6 pp 1067-1076
DOI: 10.1113/expphysiol.2007.038166
© The Physiological Society 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/6/1067    most recent
expphysiol.2007.038166v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hercule, H. C.
Right arrow Articles by Gollasch, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hercule, H. C.
Right arrow Articles by Gollasch, M.
Vascular

The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK {alpha} channel subunit in rodents

Hantz C. Hercule1, Birgit Salanova1, Kirill Essin1,2, Horst Honeck3, John R. Falck4, Matthias Sausbier5, Peter Ruth5, Wolf-Hagen Schunck3, Friedrich C. Luft1 and Maik Gollasch2

1 Nephrology/Hypertension Division, Franz Volhard Clinic, HELIOS Klinikum-Berlin, Campus Buch, Berlin, Germany 2 Medical Faculty of the Charité, Nephrology/Intensive Care Division, Campus Virchow, Berlin, Germany 3 Max Delbrück Center for Molecular Medicine, Campus Buch, Berlin, Germany 4 Department of Biochemistry and Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA 5 Department of Pharmacology and Toxicology, Institute of Pharmacy, University of Tübingen, Tübingen, Germany

17,18-Epoxyeicosatetraenoic acid (17,18-EETeTr) stimulates vascular large-conductance K+ (BK) channels. BK channels are composed of the pore-forming BK {alpha} and auxiliary BK β1 subunits that confer an increased sensitivity for changes in membrane potential and calcium to BK channels. Ryanodine-sensitive calcium-release channels (RyR3) in the sarcoplasmic reticulum (SR) control the process. To elucidate the mechanism of BK channel activation, we performed whole-cell and perforated-patch clamp experiments in freshly isolated cerebral and mesenteric artery vascular smooth muscle cells (VSMC) from Sprague–Dawley rats, BK β1 gene-deficient (–/–), BK {alpha} (–/–), RyR3 (–/–) and wild-type mice. The 17,18-EETeTr (100 nM) increased tetraethylammonium (1 mM)-sensitive outward K+ currents in VSMC from wild-type rats and wild-type mice. The effects were not inhibited by the epoxyeicosatrienoic acid (EET) antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (10 µM). BK channel currents were increased 3.5-fold in VSMC from BK β1 (–/–) mice, whereas a 2.9-fold stimulation was observed in VSMC from RyR3 (–/–) mice (at membrane voltage 60 mV). The effects were similar compared with those observed in cells from wild-type mice. The BK current increase was neither influenced by strong internal calcium buffering (Ca2+, 100 nM), nor by external calcium influx. The 17,18-EETeTr did not induce outward currents in VSMC BK {alpha} (–/–) cells. We next tested the vasodilator effects of 17,18-EETeTr on isolated arteries of BK {alpha}-deficient mice. Vasodilatation was largely inhibited in cerebral and mesenteric arteries isolated from BK {alpha} (–/–) mice compared with that observed in wild-type and BK β1 (–/–) arteries. We conclude that 17,18-EETeTr represents an endogenous BK channel agonist and vasodilator. Since 17,18-EETeTr is active in small arteries lacking BK β1, the data further suggest that BK {alpha} represents the molecular target for the principal action of 17,18-EETeTr. Finally, the action of 17,18-EETeTr is not mediated by changes of the internal global calcium concentration or local SR calcium release events.

(Received 18 April 2007; accepted after revision 20 July 2007; first published online 3 August 2007)
Corresponding author M. Gollasch: Charité University Medicine, Nephrology and Intensive Care, Augustenburger Platz 1, 13353 Berlin, Germany. Email: maik.gollasch{at}charite.de







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the The Physiological Society.